Mosaic ImmunoEngineering (OTCMKTS:CPMV) Announces Quarterly Earnings Results

Mosaic ImmunoEngineering (OTCMKTS:CPMV) announced its quarterly earnings data on Tuesday. The company reported ($0.02) earnings per share for the quarter, Zacks reports.

Mosaic ImmunoEngineering Stock Performance

CPMV opened at $0.4980 on Thursday. The firm’s fifty day moving average is $0.43 and its two-hundred day moving average is $0.62. The firm has a market cap of $3.61 million, a PE ratio of -4.98 and a beta of -1.18. Mosaic ImmunoEngineering has a twelve month low of $0.2520 and a twelve month high of $1.00.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.